The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

1. Herpes Simplex Infections - Pipeline Review, H1 2014
This report provides comprehensive information on the therapeutic development for Herpes Simplex Infections, complete with comparative analysis at various
stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and
featured news and press releases. It also reviews key players involved in the therapeutic development for Herpes Simplex Infections and special features on
late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
The report provides a snapshot of the global therapeutic landscape of Herpes Simplex Infections The report reviews key pipeline products under drug profile
section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key
players involved in the therapeutics development for Herpes Simplex Infections and enlists all their major and minor projects The report summarizes all the
dormant and discontinued pipeline projects A review of the Herpes Simplex Infections products under development by companies and universities/research
institutes based on information derived from company and industry-specific sources Pipeline products coverage based on various stages of development ranging
from pre-registration till discovery and undisclosed stages A detailed assessment of monotherapy and combination therapy pipeline projects Coverage of the
Herpes Simplex Infections pipeline on the basis of target, MoA, route of administration and molecule type Latest news and deals relating related to pipeline
products Reasons to buy
Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players
with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Develop strategic initiatives by understanding the
focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Herpes Simplex Infections Plan
mergers and acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects by understanding
Herpes Simplex Infections pipeline depth and focus of Indication therapeutics Develop and design in-licensing and out-licensing strategies by identifying
prospective partners with the most attractive projects to enhance and expand business potential and scope Modify the therapeutic portfolio by identifying
discontinued projects and understanding the factors that drove them from pipeline
table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 5
introduction 7
global Markets Direct Report Coverage 7
herpes Simplex Infections Overview 8
therapeutics Development 9
pipeline Products For Herpes Simplex Infections Overview 9
pipeline Products For Herpes Simplex Infections Comparative Analysis 10
herpes Simplex Infections Therapeutics Under Development By Companies 11
herpes Simplex Infections Therapeutics Under Investigation By Universities/institutes 15
herpes Simplex Infections Pipeline Products Glance 17
late Stage Products 17
clinical Stage Products 18
early Stage Products 19
herpes Simplex Infections Products Under Development By Companies 20
herpes Simplex Infections Products Under Investigation By Universities/institutes 22
herpes Simplex Infections Companies Involved In Therapeutics Development 23
vical Incorporated 23
sanofi 24
genvec, Inc. 25
astellas Pharma Inc. 26
cel-sci Corporation 27
mymetics Corporation 28
novabay Pharmaceuticals, Inc. 29
nutra Pharma Corporation 30
peregrine Pharmaceuticals, Inc. 31
oryzon Genomics S.a. 32
colby Pharmaceutical Company 33
osel Inc. 34
alphavax, Inc. 35
romark Laboratories, L.c. 36
Herpes Simplex Infections - Pipeline Review, H1 2014

2. chimerix, Inc. 37
nanobio Corporation 38
immunovaccine, Inc. 39
immune Design Corp. 40
seek 41
adamis Pharmaceuticals Corporation 42
vaxart, Inc. 43
genocea Biosciences, Inc. 44
profectus Biosciences, Inc. 45
3-v Biosciences, Inc. 46
spider Biotech S.r.l. 47
kala Pharmaceuticals, Inc. 48
coridon Pty Ltd 49
sanofi Pasteur Sa 50
humabs Biomed Sa 51
bioapex, S.r.o. 52
herpes Simplex Infections Therapeutics Assessment 53
assessment By Monotherapy Products 53
assessment By Combination Products 54
assessment By Target 55
assessment By Mechanism Of Action 58
assessment By Route Of Administration 61
assessment By Molecule Type 63
drug Profiles 66
amenamevir - Drug Profile 66
tenofovir - Drug Profile 67
rpi-78m - Drug Profile 69
rpi-mn - Drug Profile 71
hsv-2 Vaccine - Drug Profile 73
gen-003 - Drug Profile 75
herpes Simplex Virus Type 2 Vaccine - Drug Profile 77
hsv-529 - Drug Profile 78
id-g103 - Drug Profile 80
brincidofovir - Drug Profile 81
cel-1000 - Drug Profile 83
hsv Vaccine - Drug Profile 85
hsv-2 Vaccine - Drug Profile 86
c-31-g - Drug Profile 87
mucocept Platform - Drug Profile 89
hsv-2 Px - Drug Profile 90
nvc-727 - Drug Profile 91
jvrs-100 + Herpes Simplex Virus-2 Vaccine - Drug Profile 92
drug For Herpes Simplex - Drug Profile 94
pgn-632 - Drug Profile 95
gv-2207 - Drug Profile 96
acyclovir - Drug Profile 97
sb-105 - Drug Profile 98
plantibodies - Drug Profile 99
azuvirins - Drug Profile 100
herpes Simplex Virus Vaccine - Drug Profile 101
mb-66 - Drug Profile 102
small Molecule Targeting Fatty Acid Synthase For Infectious Disease - Drug Profile 103
ba-368 - Drug Profile 104
hsv-2 Vaccine - Drug Profile 105
rkp-00156 - Drug Profile 106
cel-1000 - Drug Profile 107
mab Hu2c - Drug Profile 108
hsv Vaccine - Drug Profile 109
therapeutic/prophylactic Vaccine Program For Herpes Simplex Virus - Drug Profile 110
new Thiazolides - Drug Profile 111
small Molecule To Inhibit Lsd-1 For Hsv - Drug Profile 112
els-120 - Drug Profile 113
rc-100b - Drug Profile 114
drug For Herpes Simplex Virus - Drug Profile 116
subunit Vaccine For Herpes Simplex Virus 2 - Drug Profile 117
small Molecules For Viral Infections - Drug Profile 118
mab Against Hsv-1/2 - Drug Profile 119
labyrinthopeptine A1 - Drug Profile 120
Herpes Simplex Infections - Pipeline Review, H1 2014

3. lipopeptide Vaccine For Hsv Infections - Drug Profile 121
small Molecules For Viral Infections - Drug Profile 122
small Molecules For Bacterial And Viral Infections - Drug Profile 123
herpes Simplex Infections Recent Pipeline Updates 124
herpes Simplex Infections Dormant Projects 139
herpes Simplex Infections Discontinued Products 140
herpes Simplex Infections Product Development Milestones 141
featured News & Press Releases 141
appendix 150
methodology 150
coverage 150
secondary Research 150
primary Research 150
expert Panel Validation 150
contact Us 151
disclaimer 151
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Herpes Simplex Infections - Pipeline Review, H1 2014